The study, which was published in the British Journal of Pharmacology, found that CBGA was the most potent of the three and may also affect many of the same therapeutic targets that are targeted by traditional anti-epilepsy drugs.
Published in the Journal of Clinical Pharmacology, the study surveyed the first group of UK chronic pain patients prescribed medical cannabis oil.
People with a history of cannabis use in their medical records appear to be at a higher risk for developing problems with anxiety, depression, and even more severe mental illnesses such as schizophrenia, according to a new study from researchers at the University of Birmingham.
Exposure to THC in the womb could increase the risk that genetically predisposed children are born with facial defects, according to a new rodent study published in the journal Development.
The US city of Seattle has become the largest city in the country to decriminalize the use of some psychedelic substances, including psilocybin and mescaline.
Many hemp farmers in Oregon are growing something a bit stronger than advertised, according to a new report from state regulators.
Ketamine alone may be just as effective as ketamine combined with traditional antidepressants for tackling treatment-resistant depression, a new study has found.
The affected marijuana material ended up in several products, including bud, pre-packaged bud, and pre-roll joints.